What is ADHD?
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent symptoms of inattention, hyperactivity, and impulsivity that cause significant impairment across multiple settings and are not better explained by another mental disorder. 1
Core Characteristics and Diagnostic Criteria
ADHD presents with two primary symptom domains:
Inattentive Symptoms
- Poor attention to detail/careless mistakes
- Difficulty concentrating or sustaining attention on tasks
- Seeming preoccupied, difficulty shifting focus even when spoken to directly
- Difficulty completing tasks (gets distracted/sidetracked)
- Organizational challenges (chronic lateness, messiness, disorganized work)
- Reluctance to engage in tasks requiring sustained mental effort
- Difficulty keeping track of belongings
- Easily distracted
- Frequently forgetful 1, 2
Hyperactive-Impulsive Symptoms
- Frequent fidgeting
- Difficulty sitting still for prolonged periods
- Inner restlessness or agitation
- Disruptive behavior
- Always "on the go"
- Excessive talking
- Interrupting others
- High impatience
- Intrusive behavior 1
For diagnosis, symptoms must:
- Be present before age 12
- Persist for at least 6 months
- Occur in 2 or more settings (e.g., home, school/work)
- Cause significant impairment in functioning
- Not be better explained by another mental disorder 2
Types of ADHD
ADHD is classified into three presentations:
- Predominantly Inattentive Type: 5+ inattentive symptoms, <5 hyperactive-impulsive symptoms
- Predominantly Hyperactive-Impulsive Type: 5+ hyperactive-impulsive symptoms, <5 inattentive symptoms
- Combined Type: 5+ symptoms in both categories 1
Epidemiology and Course
- ADHD affects approximately 8% of children and youth 1
- 14.6% of U.S. adults meet DSM-5 criteria for ADHD 3
- ADHD diagnosed in childhood often persists into adulthood 3
- Adults with ADHD are more likely to present with inattentive symptoms 1
- ADHD is a chronic condition requiring ongoing management 1
Etiology
The specific etiology of ADHD is unknown, but evidence suggests:
- Neurobiological basis involving norepinephrine and dopamine dysregulation in brain areas responsible for attention and behavior regulation 4
- Genetic factors contribute to heritability, though no single genetic marker has been consistently identified 5
- Environmental factors may play a role in symptom expression and severity
Common Comorbidities
ADHD frequently co-occurs with:
- Emotional/behavioral disorders (anxiety, depression, oppositional defiant disorder, conduct disorder)
- Developmental conditions (learning disorders, language disorders)
- Physical conditions (tics, sleep disorders)
- Substance use disorders (especially in untreated adolescents and adults) 1, 3
Comorbidity rates range from 12-60%, with significant symptom overlap that can complicate diagnosis 5.
Assessment and Diagnosis
Diagnosis requires:
- Comprehensive clinical history and evaluation
- Assessment using validated rating scales (e.g., Adult ADHD Self-Report Scale, Conners' Adult ADHD Rating Scales)
- Collection of information from multiple sources (parents, teachers, self-report)
- Ruling out alternative explanations for symptoms 3
Treatment Approaches
Treatment is multimodal and should be tailored to the individual:
Pharmacological Treatment
- First-line medications: Stimulants (methylphenidate and amphetamine derivatives) 6, 7
- Non-stimulant options: Atomoxetine, viloxazine, bupropion (especially for those with comorbid anxiety/depression) 6, 2
- Medications should be carefully monitored for cardiovascular effects, though serious adverse events are rare 7
Non-pharmacological Approaches
- Evidence-based parent training and behavioral management (first-line for children 4-6 years) 6
- Cognitive-behavioral therapy focused on organization skills, time management, and emotional regulation 6
- Educational interventions and accommodations 6
- Psychosocial interventions 1
Regional Differences in Treatment Approaches
Treatment guidelines vary globally:
- Western guidelines often recommend FDA-approved medications along with behavioral interventions 1
- Japanese guidelines recommend school environment management and psychosocial treatment as first-line, with medications as second-line 1
- Treatment approaches should consider cultural and regional contexts 1
Pitfalls in Diagnosis and Management
- Misattribution of symptoms to other conditions (especially in adults)
- Inadequate assessment of comorbidities
- Insufficient dosing of medications
- Lack of multimodal treatment approach
- Failure to monitor treatment response and adjust accordingly 6
ADHD is a complex neurodevelopmental disorder requiring comprehensive assessment and individualized treatment to address symptoms and improve quality of life across multiple domains.